Quick Takeaways
- Jack A. Khattar has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $113,264,972.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Jack A. Khattar and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | President, CEO, Director | $113,252,362 | -$20,309,838 | -15% | 13 Mar 2026 |
| CGTX | COGNITION THERAPEUTICS INC | Director | $12,610 | 18 Jun 2025 | ||
| SCPH | scPharmaceuticals Inc. | Director | $0 | 07 Oct 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|